Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis Interventions: Drug: Remestemcel-L; Other: Placebo Sponsors: The Cleveland Clinic; Mesoblast, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Inflammatory Bowel Disease | Research | Stem Cell Therapy | Stem Cells | Study | Ulcerative Colitis